Jula Inrig - Net Worth and Insider Trading

Jula Inrig Net Worth

The estimated net worth of Jula Inrig is at least $1 Million dollars as of 2025-07-24. Jula Inrig is the CHIEF MEDICAL OFFICER of Travere Therapeutics Inc and owns about 88,787 shares of Travere Therapeutics Inc (TVTX) stock worth over $1 Million. Details can be seen in Jula Inrig's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jula Inrig has not made any transactions after 2025-07-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Jula Inrig

To

Jula Inrig Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jula Inrig owns 1 companies in total, including Travere Therapeutics Inc (TVTX) .

Click here to see the complete history of Jula Inrig’s form 4 insider trades.

Insider Ownership Summary of Jula Inrig

Ticker Company Transaction Date Type of Owner
TVTX Travere Therapeutics Inc 2025-07-01 Chief Medical Officer

Jula Inrig Latest Holdings Summary

Jula Inrig currently owns a total of 1 stock. Jula Inrig owns 88,787 shares of Travere Therapeutics Inc (TVTX) as of July 1, 2025, with a value of $1 Million.

Latest Holdings of Jula Inrig

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TVTX Travere Therapeutics Inc 2025-07-01 88,787 15.85 1,407,274

Holding Weightings of Jula Inrig


Jula Inrig Form 4 Trading Tracker

According to the SEC Form 4 filings, Jula Inrig has made a total of 8 transactions in Travere Therapeutics Inc (TVTX) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Travere Therapeutics Inc is the sale of 815 shares on July 1, 2025, which brought Jula Inrig around $11,940.

Insider Trading History of Jula Inrig

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jula Inrig Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jula Inrig Ownership Network

Ownership Network List of Jula Inrig

No Data

Ownership Network Relation of Jula Inrig

Insider Network Chart


Jula Inrig Owned Company Details

What does Travere Therapeutics Inc do?

Who are the key executives at Travere Therapeutics Inc?

Jula Inrig is the Chief Medical Officer of Travere Therapeutics Inc. Other key executives at Travere Therapeutics Inc include Senior Vice President & R&D William E. Rote , Chief Financial Officer Christopher R. Cline , and director & Chief Executive Officer Eric M Dube .

Travere Therapeutics Inc (TVTX) Insider Trades Summary

Over the past 18 months, Jula Inrig made 6 insider transaction in Travere Therapeutics Inc (TVTX) with a net sale of 14,037. Other recent insider transactions involving Travere Therapeutics Inc (TVTX) include a net sale of 10,947 shares made by Christopher R. Cline , a net sale of 112,851 shares made by Eric M Dube , and a net sale of 85,607 shares made by Sandra Calvin .

In summary, during the past 3 months, insiders sold 31,412 shares of Travere Therapeutics Inc (TVTX) in total and bought 0 shares, with a net sale of 31,412 shares. During the past 18 months, 398,664 shares of Travere Therapeutics Inc (TVTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 398,664 shares.

Travere Therapeutics Inc (TVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Travere Therapeutics Inc Insider Transactions

No Available Data

Jula Inrig Mailing Address

Above is the net worth, insider trading, and ownership report for Jula Inrig. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jula Inrig's mailing address is: San Diego Ca 92130.